Hong Kong (China)
China’s PE-backed Tubatu files for HK IPO
Tubatu, a Chinese online home renovation platform backed by Matrix Partners and Sequoia Capital, has filed for an IPO in Hong Kong.
CDH-backed Mabpharm files for Hong Kong IPO
Mabpharm, a China-based biopharmaceutical company backed by CDH Investments, has filed for an IPO in Hong Kong, the latest in a growing number of proposed listings under new rules that allow biotech companies with no revenue or profits to go public.
China’s Ascentage Pharma files for HK IPO
Ascentage Pharma, a Chinese biopharmaceutical company with several private equity backers, has filed for an IPO in Hong Kong.
China's PE-backed AsiaInfo files for HK IPO
AsiaInfo Technologies, a Chinese telecommunications software provider backed by a number of private equity firms, has filed for a Hong Kong IPO.
Blackstone to invest $400m in Hong Kong-listed HEC Pharm
The Blackstone Group has agreed to invest $400 million in YiChang HEC Changjiang Pharmaceutical (HEC Pharm), a Chinese drug developer listed in Hong Kong, through a convertible bond issuance.
TPG, MBK agree sale of Wharf T&T to Hong Kong’s HKBN
TPG Capital and MBK Partners have agreed to sell Hong Kong telecom services provider Wharf T&T to internet service provider Hong Kong Broadband Network (HKBN) at an enterprise valuation of HK$10.5 billion ($1.3 billion).
Hong Kong's Klook gets $200m Series D
Hong Kong travel services company Klook has closed a $200 million Series D funding round from a group of investors including Sequoia Capital China, Matrix Partners, and Goldman Sachs.
China's PE-backed Weimob applies for HK IPO
Weimob, a Shanghai-based provider of marketing and cloud services to online merchants that is backed by Tencent Holdings and several private equity firms, has filed for an IPO in Hong Kong.
PE-backed China Everbright Water files for HK IPO
China Everbright Water, a Singapore-listed water environmental solutions provider focused on China and backed by RRJ Capital and the International Finance Corporation (IFC), has filed for a dual listing in Hong Kong.
CVC invests $255m in China toll road operator
CVC Capital Partners has agreed to invest HK$2 billion ($255 million) in RKE International Holdings, a Chinese toll road operator and subsidiary of Hong Kong-listed property development and infrastructure conglomerate Road King Infrastructure (RKI).
Beyond named as partner for Hong Kong venture fund
Beyond Ventures has been named as a co-investment partner for the Innovation & Technology Venture Fund (ITVF), a vehicle launched by the Hong Kong government to encourage private investment in local technology start-ups.
Campbell Lutyens appoints two principals in Hong Kong
Campbell Lutyens has appointed James Shipperlee and Don Yoon, both of whom are currently with the firm's fund placement team, as principals in its Hong Kong office.
China biotech: Finding the formula
An eruption of investment and company creation in Chinese biotech has signaled the dawn of a raw but promising market. First-movers must negotiate immediate pitfalls while targeting long-term upside
Hong Kong's GoGoVan raises $250m
Hong Kong-based last-mile logistics company GoGoVan has raised $250 million from a group of investors led by China’s InnoVision Capital.
Xiaomi raises $4.7b in Hong Kong IPO
Chinese smart phone maker Xiaomi has raised HK$37 billion ($4.72 billion) in its Hong Kong IPO at a valuation of $54 billion – well below the totals it had originally targeted.
Hong Kong's PE-backed WeLab files for IPO
WeLab, a Hong Kong financial technology provider with backers including Alibaba Group, the International Finance Corporation (IFC), and Malaysia’s Khazanah Nasional, has filed for an IPO.
Cancer drug developer Innovent Biologics files for HK IPO
Innovent Biologics, a Chinese drug developer company with a number of PE backers, has filed for an IPO in Hong Kong under recently introduced rules allowing listings by biotech companies with no revenue or profits.
PE-backed Zhaogang files Hong Kong IPO
Zhaogang, a Chinese B2B steel-trading platform operator that has raised more than RMB2 billion ($303 million) across five PE-backed funding rounds, has filed for a Hong Kong IPO.
China online travel service provider files for HK IPO
Tongcheng-eLong, a Chinese online travel services company backed by Tencent Holdings and domestic travel leader Ctrip, has filed for a Hong Kong IPO.
PE-backed VCredit raises $152m in HK IPO
VCredit, a Chinese online consumer finance platform with private equity backers including TPG Growth, has raised HK$1.2 billion ($152 million) in its Hong Kong IPO.
Beyond backs Hong Kong electric motor company
Hong Kong-based Beyond Ventures has joined a $10 million round for ePropulsion Innovation, a domestic technology developer focused on electric motors for recreational boating.
Hua Medicine files for HK IPO under biotech fastrack
Hua Medicine, a Chinese drug developer player that simultaneously closed its Series D and E funding rounds in March, has become the second company to file for a Hong Kong IPO under rules that allow zero revenue biotech businesses to go public.
Hong Kong technology IPOs: Size matters
Hong Kong has altered its IPO regime to attract tech companies with unorthodox shareholding structures and biotech start-ups with no revenue. But only certain businesses are welcome to apply
Hong Kong's Arbor raises $178.5m for second VC fund
Hong Kong-based Arbor Ventures has received $178.5 million in commitments for its second financial technology-focused venture capital fund. The targeted corpus is $220 million.